General Sessions. Moderators: Del Miles, Sheila McGuirk, Daryl Nydam

Similar documents
THIS ARTICLE IS SPONSORED BY THE MINNESOTA DAIRY HEALTH CONFERENCE.

Salmonella Dublin: Clinical Challenges and Control

Interpretation of Bulk Tank Milk Results

Presented at Central Veterinary Conference, Kansas City, MO, August 2013; Copyright 2013, P.L Ruegg, all rights reserved

Mycoplasmal pneumonia in calves

TOC INDEX. Hemophilosis. Joyce Van Donkersgoed. Take Home Message. Introduction

Mastitis: Background, Management and Control

ENVIRACOR J-5 aids in the control of clinical signs associated with Escherichia coli (E. coli) mastitis

DAIRY VETERINARY NEWSLETTER

Mycoplasma bovis Infections inyoung Calves

DeLaval Cell Counter ICC User Strategies Guide

Emerging Mastitis Threats on the Dairy Pamela Ruegg, DVM, MPVM Dept. of Dairy Science

Milk Quality Management Protocol: Fresh Cows

Strep. ag.-infected Dairy Cows

BOVINE RESPIRATORY DISEASE COMPLEX. Kristen Mierzwiak LCS 630

Controlling Contagious Mastitis

Interpretation and Use of Laboratory Culture Results and the Characteristics of Various Mastitis Pathogens

2012 Indiana Regional Dairy Meetings. Purdue University College of Veterinary Medicine Dr. Jon Townsend Dairy Production Medicine

Using SCC to Evaluate Subclinical Mastitis Cows

Walter M. Guterbock, DVM, MS Veterinary Medicine Teaching and Research Center University of California, Davis

Prototheca Mastitis in Dairy Cows

Dr. Michelle Arnold, DVM DABVP (Food Animal) Ruminant Extension Veterinarian University of Kentucky Veterinary Diagnostic Laboratory

Practical Biosecurity and Biocontainment on the Ranch

Interpretation and Use of Laboratory Culture Results and the Characteristics of Various Mastitis Pathogens

Mastitis MANAGING SOMATIC CELLS COUNTS IN. Somatic Cell Count Are Affected by. Somatic Cells are NOT Affected by:

Milk quality & mastitis - troubleshooting, control program

Milk Quality Evaluation Tools for Dairy Farmers

BIOSECURITY ON DAIRIES... ARE WE DOING ENOUGH?

Outline MILK QUALITY AND MASTITIS TREATMENTS ON ORGANIC 2/6/12

, Pamela L. Ruegg

Reproductive Vaccination- Deciphering the MLV impact on fertility

SPCA CERTIFIED. Table 1. Animal Health Response Plan. Calf mortality pre-weaning exceeds 5 % per calving season

NYS Cattle Health Assurance Program. Expansion Module Background and Best Management Practices

Dairy Calf, BVDv-PI Dead & Chronic Monitoring Program

Ren Tip # 84 11/6/15

Premiums, Production and Pails of Discarded Milk How Much Money Does Mastitis Cost You? Pamela Ruegg, DVM, MPVM University of Wisconsin, Madison

Herd Health Plan. Contact Information. Date Created: Date(s) Reviewed/Updated: Initials: Date: Initials: Date: Farm Manager: Veterinarian of Record:

Mastitis Module Risk Assessment Guide by Pathogen. Streptococcus agalactiae

Anti-microbial usage and Expectations. Gerald Stokka, DVM, MS Livestock Stewardship

Mastitis and colostrum management update. Dr Kiro Petrovski University of Adelaide, Roseworthy

May Why is Participation in Johne s Disease Testing Programs so Low, and is it Important to Increase Johne s Surveillance in the Dairy Industry?

Dry Cow Vaccination. Maternity Pen. Timing. Colostrum Absorption. Failure of Passive Transfer

The Uncommon. Bacillus cereus Clost. Perfringens Nocardia spp. Mycoplasma spp. Moulds and yeasts Pseudomonas spp.

LOOKING FOR PROFITS IN MILK QUALITY

DAIRY HERD INFORMATION FORM

MATERIALS AND METHODS

Decision tree analysis of treatment strategies for mild and moderate cases of clinical mastitis occurring in early lactation

Interpretation of results from milk samples tested for mastitis bacteria with Mastit 4 qpcr test from DNA Diagnostic

Bovine Viral Diarrhea (BVD)

Bovine respiratory disease: management and treatment

MASTITIS CASE MANAGEMENT

MASTITIS DNA SCREENING

Mastitis and On-Farm Milk Cultures - A Field Study - Part 1

TOC INDEX. Salmonellosis in Feedlot Cattle. Jane Pritchard. Take Home Message. Introduction

Simple Herd Level BVDV Eradication for Dairy

Mycoplasma bovis Infections in Cattle

Using Technology to Improve Calf Raising Sam Barringer, DVM Merck Animal Health

Update on Staphylococcus aureus Mastitis. John R. Middleton College of Veterinary Medicine, University of Missouri, Columbia

Practical Biosecurity and Biocontainment on the Ranch. Dale Grotelueschen, DVM, MS Great Plains Veterinary Educational Center Clay Center, NE

Mastitis in non-bovine dairy species, companion animals and breastfeeding mothers. Chris Knight

Payback News. Beef Herd Nutrition Challenges

Using DHIA and bacteriology to investigate herd milk quality problems.

Comparative efficacy of DRAXXIN or Nuflor for the treatment of undifferentiated bovine respiratory disease in feeder cattle

Use of a novel adjuvant to enhance the antibody response to vaccination against Staphylococcus aureus mastitis in dairy heifers.

TIMELY INFORMATION Agriculture & Natural Resources

Break Free from BVD. What is BVD? BVD outbreak in 2013/ cow dairy herd in Staffordshire. Costs Calculation Costs*

THIS ARTICLE IS SPONSORED BY THE MINNESOTA DAIRY HEALTH CONFERENCE.

Bacterial Pneumonia in Sheep, The Domestic Bighorn Sheep Interface, and Research at ADRU

April Boll Iowa State University. Leo L. Timms Iowa State University. Recommended Citation

Transition Period 1/25/2016. Energy Demand Measured glucose supply vs. estimated demands 1

Feline Vaccines: Benefits and Risks

The world s first and only pour-on anti-inflammatory for cattle FAST PAIN RELIEF

Charmany Dairy Herd Newsletter Oct. 29 th Nov. 4 th Daily Events

Finnzymes Oy. PathoProof Mastitis PCR Assay. Real time PCR based mastitis testing in milk monitoring programs

HUSK, LUNGWORMS AND CATTLE

Clinical Manifestations and Treatment of Plague Dr. Jacky Chan. Associate Consultant Infectious Disease Centre, PMH

Lactation. Macroscopic Anatomy of the Mammary Gland. Anatomy AS 1124

What is Dairy Production Medicine?

GHI-Thailand Dairy farming in Chiang Mai, Thailand. Khwanchai Kreausukon Faculty of Veterinary Medicine Chiang Mai University

Emerging Bovine Health Issues. February 2019 MREC-Minneapolis Brandon Treichler, DVM

Diagnosis, treatment and control: dealing with coccidiosis in cattle

Influence of Management Techniques on the Levels of Mastitis in an Organic Dairy Herd Mastitis management in organic herd

Stronger Together Minnesota Dairy Growth Summit February 9 th, Trevor Ames DVM MS DACVIM Professor and Dean

Veterinaria.com.pt 2009; Vol. 1 Nº 1: e13 (publicação inicial em Julho de 2008) Disponível em

however, the mild weather and moisture we have had these past couple of weeks have been

Johne s Disease Control

Case Study: Dairy farm reaps benefits from milk analysis technology

Multi-state MDR Salmonella Heidelberg outbreak associated with dairy calf exposure

NYSCHAP BASELINE SURVEY Cover Page

Salmonella Heidelberg: An Emerging Problem in the Dairy Industry

Reedy Fork Dairy Farm Parasitology Report Fall 2016

Innovation in Mastitis Treatment

How to stop the snotty noses: Preventing feline upper respiratory infections. Staci Cannon, DVM, MPH, DACVPM, DABVP (Shelter Medicine Practice)

MALLA HOVI & STEVE RODERICK, Veterinary Epidemiology and Economics Unit, University of Reading, PO Box 236, READING RG6 6AT

Guideline on the conduct of efficacy studies for intramammary products for use in cattle

Lumpy-skin disease. a disease of socio-economic importance. Knopvelsiekte (Afrikaans) Letlalo la goba le diso (Sotho) Lindsay Thomas

Factors Affecting Calving Difficulty and the Influence of Pelvic Measurements on Calving Difficulty in Percentage Limousin Heifers

ASSESSMENT, SCORING AND DISEASE MANAGEMENT OF DAIRY CALVES

Canine Anaplasmosis Anaplasma phagocytophilum Anaplasma platys

Eradication of Johne's disease from a heavily infected herd in 12 months

Transcription:

General Sessions Moderators: Del Miles, Sheila McGuirk, Daryl Nydam Transmission of Mycoplasma bovis and the Syndromes that Result in Beef and Dairy Cattle Ricardo F. Rosenbusch, DVM, MS, PhD Dept. of Veterinary Microbiology and Preventive Medicine, College of Veterinary Medicine, Iowa State University, Ames, IA 50011 Abstract Infections with Mycoplasma bovis can result in several syndromes of importance for dairy and beef cattle of all ages. These diseases continue to require the attention of practitioners due to poor response to treatment and the marginal effectiveness of prophylaxis. We explore here parameters of transmission of the infections, and how practitioners can use this knowledge to develop management strategies. General concepts about transmission of the mycoplasma are followed with specific description of several different mycoplasma mastitis clinical presentations. Issues with transmission and mastitis are outlined. Pneumonia and polyarthritis, and middle ear infections in dairy calves are described next and transmission of infection differences are highlighted. Examples of presentations of pneumonia and polyarthritis in beef calves are presented together with discussion of some of the transmission questions that are commonly raised when considering this disease. Introduction Infections with Mycoplasma bovis will present themselves with several well-defined clinical syndromes. All of these can potentially be seen in dairy or beef cattle, yet several of the syndromes will preferentially be seen in specific age groups of beef or dairy cattle. Due to the infectious nature of these syndromes, modes of transmission as well as susceptibility of the cattle population at risk dictate which syndrome will be frequently encountered. Here we explore these modes of transmission, and correlate them with specific susceptibility attributes of dairy and beef cattle of various age groups. Transmission of M. bovis is affected by several variables. Cattle are usually susceptible to infection by multiple routes, although the infectious dose of agent needed to establish infection may vary widely among portals of entry. It is accepted that 100 cfu (colony forming units) of M. bovis can initiate a nasal or mammary infection, 1 while 10 6 cfu or more are needed to set up a lower respiratory tract infection, and much higher doses for systemic infection by the oral route. 10 Contagiousness of the infection is determined by the capacity of the pathogen to replicate at the portal, time-delay in becoming a contagious carrier, and duration of the contagious stage. Nasal infection will need five days to reach peak infectivity at 10 8 cfu/ml, and shedding will continue for several months. Mammary infection will need 2-3 days to reach peak levels of 10 9 cfu and shedding in secretions will continue for the duration of lactation, although it is intermittent after the first month. 7 Dry quarters may shed mycoplasma (milking claw applied in error), and flare-ups at freshening are seen in many cows. Thus, natural or disease-enhanced dissemination of fomites from the colonized portal play a major role in successful contagion. In addition, environmental contamination is presumed to occur as deduced from seeding trials, 12 although there is lack of well-documented evidence of its occurrence in the field. Transmission of the infection must also be contrasted with clinical presentation. It is known that the proportion of cattle infected with M. bovis well exceeds that of clinically affected cattle, and in some cases, infection is documented without clinically relevant presentations (the over-diagnosis problem). 5 Depending on the portal of entry, dissemination of mycoplasma from the portal may or may not be necessary before clinical signs ensue. This dissemination can occur by normal host defense mechanisms (migration of mycoplasma-loaded dendritic cells and macrophages) and/or by specific virulence attributes of the pathogen. SEPTEMBER, 2005 1

As occurs with other pathogenic mycoplasmas, virulence factors of M. bovis, while inferred to exist, are still poorly defined. In Table 1, several strains of M. bovis with diverse pathogenic potential are compared in a model of intratracheal infection in naïve weaned dairy calves. When a dose of 10 10 cfu (colony forming units) is presented at the tracheal bifurcation, some strains will rapidly establish mycoplasmemia and febrile response. Strains may also destroy the tracheal escalator and not allow recovery from the nose in this model. All evidence to date suggests that even though these variations in virulence exist among strains of M. bovis, specific types of strains are not associated with specific syndromes. 13 Rather, any strain can cause each syndrome, with more or less severity, depending on the presence and strength of expression of these yet unknown virulence factors. Following are descriptions of the more common syndromes seen with M. bovis infections in cattle. Mastitis Mastitis caused by M. bovis will be seen in both dairy and beef cattle. In dairy cows where the problem is most commonly reported, several forms can be described. Acute mastitis associated with herd expansion is seen infrequently although it is a costly presentation. A midwest dairy herd of 130 cows was commingled with 180 purchased cows, and introduced into a new milking parlor. Within a week, a few cows were reported with single non-secreting quarters. Rapid progression to full agalactia followed, and affected cows were febrile. By 15 days, there were 12 cows with severe mastitis. These cows were from the home herd as well as the purchased herd, and in both early and late lactation. Affected cows appeared to respond to antibiotic treatment with slight recovery of milk secretion, then relapsed with severe mastitis, and most of these also presented polyarthritis involving knees, hocks and shoulder joints, as well as signs of pneumonia. Culture from affected quarters milk yielded M. bovis, and segregated milking of all abnormal milk cows was instituted. At one month of commingling there were 20 cows dead or salvaged, and bulk tank samples from all clean strings tested negative for mycoplasma. At three months, composite samples from all cows in the hospital pen yielded 25% culturepositive cows, and the entire hospital group was culled. At 3.5 months, bulk tank samples from the healthy group tested positive for M. bovis and it was decided to culture all remaining cows individually. The five culture-positive cows identified were also culled. Overall losses (from all causes) by four months were 115/310 cows, or 37% of initially lactating cows. Bulk tank samples taken at 5, 6 and 7 months after commingling were negative. Serology done on all remaining cows at 6 months after commingling revealed that 70% were seropositive, evenly dispersed among the home and purchased herds. No samples were taken to determine transmission patterns in this outbreak, although the ELISA serology data clearly indicated that some of the cows in the home and purchased herd were initially naïve to M. bovis infection, and remained so throughout the episode. In our hands, ELISA serology will detect exposure within 2-3 weeks, such as nasal colonization, even in absence of disease. Nose-to-nose transmission here presumably evolved independent of mammary infection. Transmission between quarters and among udders would have occurred primarily through milking parlor activity. Nose-to-udder transmission could have accounted for the initial cases, and for cases at 3.5 months in the healthy group. Recurrent mastitis can be seen in herds that have recovered from acute mycoplasmal mastitis. These herds will undergo three or more episodes a year, 2 each one involving some cows that have mild alterations in milk secretion (abnormal quantity of flecks). These are often freshening cows, and the infection may not be detected if sampling is only done from the bulk tank. The herds often have increasing SSC and many cows with environmental mastitis. It is a good idea to review treatment protocols in farms with recurrent mycoplasmal mastitis. Eliminate the practice of compounding mastitis treatment tubes! Heifer mastitis occurs in herds that bring in bred replacement heifers from commercial sources. These heifers present with mastitis that is resistant to treatment at freshening, and they can be a source of infection for the herd. In these frequent situations, all fresh cows and all clinically affected cows need to be cultured for mycoplasma and kept separate from the main herd until results are at hand. Positive cows need to be culled. Table 1. Intratracheal pathogenicity of Mycoplasma bovis strains for naïve 8 to 12-week-old Holstein calves. Strain No. of calves Clinical signs Culture positive from Lung lesion Fever Arthritis Nose Blood Joints score M23 6 6/6 0/6 0/6 6/6 1/6 2.4±1.2 M45 4 1/4 0/4 3/4 0/4 0/4 0.5±0.2 428E 5 2/5 1/5 5/5 1/5 1/5 14.4±4.7 2 THE AABP PROCEEDINGS VOL. 38

Separating hospital and fresh cows into multiple strings can reduce mycoplasma transmission among them. Mycoplasma mastitis diagnosis will often only be done at the Mycoplasma genus level (whether culture or PCR is used). These incomplete diagnostic results may add more questions than they answer for the practitioner. In Table 2, mycoplasma species known to cause bovine mastitis are listed, together with their common presentations and transmissibility. Two species of mycoplasma are involved in acute outbreaks and recurrent mastitis presentations of significant severity. These are M. bovis and M. californicum, with the former being the most frequent. Both species are highly transmissible. Other species are not as transmissible to udders, and some are highly transmissible but not very pathogenic. These characteristics need to be taken into account when analyzing species-specific diagnostic results, clinical presentations and sampling practices. Pneumonia and Polyarthritis in Dairy Calves With the increasing size of modern dairies has come the practice of feeding discard milk to calves. The practice has shown economic advantages, as well as improved weight gain and health status among calves. 6 Discard milk from mycoplasma shedders can cause explosive presentations in calves. 4 Calves fed contaminated milk will present with pneumonia within two weeks of birth, and may also exhibit polyarthritis starting at three weeks. Large dairies that feed discard milk will routinely pasteurize the product, so that these outbreaks are now associated with pasteurizer malfunction, or post-pasteurization recontamination. The latter can occur in calf ranches that purchase pasteurized discard milk from multiple sources. Transmission in outbreaks is by oral route, and it has been shown that in very young calves M. bovis can establish intestinal infection after oral infection. This leads to septicemia and infection of multiple organs, in addition to pneumonia and polyarthritis.8 The infectious dose needed for these oral transmissions is not known precisely, but it is presumed that it is much higher that what is needed for nasal or mammary infection. 10 Of note, colostral anti-mycoplasmal antibody, although usually plentiful, is not protective against infection. Transmission concerns can have important economic repercussions. A Professional Heifer Association farmer has been raising dairy heifers and bulls from commingle sources. A bull calf presented with pneumonia and polyarthritis at six weeks of age. A joint tap sample was used to provide a positive diagnosis of M. bovis. Shortly after, several heifer calves presented with nasal discharge, bronchitis and a few had head tilt. The farmer had serology done on all calves at entry to the farm, and calves were all seropositive for M. bovis. Confronted with buyers reluctant to purchase heifers from him, he claimed that M. bovis was only present in the bull calf. The example serves to illustrate that commingle operations raising dairy heifers are a significant risk for dairy farms. The risk can presumably be reduced or controlled by raising these heifers in small isolated groups, and testing nasal swab samples for M. bovis, rather than relying on serology. Dairy farms that receive heifers from an integrated operation that does not commingle are at much lower risk of introducing a strain of M. bovis of higher virulence than the resident strain found in the noses of their cows. Middle Ear Infections Middle ear infections with M. bovis can be seen in calves of all ages, and also in cows, including dairy and beef cattle. However, reports of high incidence outbreaks are primarily associated with large dairy heifer farms, dairy beef calf farms, or veal farms. The condition is observed in either bucket or nipple-fed newborn calves. Calves present with conjunctivitis within one week of arrival, and then with droopy ears starting at two weeks. Calves evolve to bilateral otitis media and head tilt, become febrile and pneumonic. The conditions are re- Table 2. Mycoplasmas causing bovine mastitis: clinical signs and transmission. Mycoplasma species Occurrence Clinical signs Transmission M. bovis Very frequent Mastitis, arthritis, pneumonia High M. californicum Frequent Mastitis, arthritis, pneumonia High M. bovigenitalium Frequent Mastitis Low M. alkalescens Infrequent Mastitis Low M. canadense Sporadic Mastitis Very low M. dispar Sporadic Mastitis Low M. sp. serogroup 7 Frequent Mild mastitis High Acholeplasma sp. Sporadic Mild mastitis High M. arginini Sporadic Mild mastitis High SEPTEMBER, 2005 3

sistant to antimicrobial treatment unless started very early. Also, response to vaccination is generally poor. Transmission is by oral route when a calf is fed contaminated colostrums, or during prolonged and commingled transportation to rearing farms. It has been observed that in very young calves, infection by any route results in elevated colonization by mycoplasma in tonsils and pharyngeal lymphoid tissues. This may be due to preferential homing of activated macrophages to these sites, and these cells will carry live mycoplasma on their surfaces. Local immunosuppression will result from direct killing 15 or inhibition of lymphocytes in these tissues. These calves develop very high concentrations of M. bovis in the pharynx and ascending infection of middle ears is presumed. All outbreaks of middle ear infections in young dairy calves have been associated with M. bovis to date. Pneumonia and Polyarthritis in Stocker Calves Figure 1. Number of dead calves and cumulative percentage nasal positive to M. bovis for 3-day intervals starting on designated day after exposure. Sampling done at the feedyard. A load of 720 calves was shipped from order buyer premises with two positive shedder calves per truck. Pneumonia and polyarthritis caused by M. bovis can be seen infrequently in pre-weaned beef calves, and then under conditions of high stress and exposure to infection (forced commingling as occurs in dry lot calving). 3 Most occurrences of pneumonia and polyarthritis are seen in stocker calves purchased from order buyers and then shipped long distances. Recent studies document that calves from Southeastern states arrive at small stocker operations in these same states naïve to M. bovis. Commingling of susceptible calves with a few infected calves then leads to rapid dissemination of the infection. In Figure 1, rapid nasal infection is demonstrated among calves at arrival to feedyard after they have been commingled during transport with a known infection source. This can set up an acute presentation, where clinical manifestations are seen as early as two weeks after arrival, and the disease course is completed by 4-6 weeks. The following is an example of one such outbreak. A midwestern lot received 200 light beef calves averaging 450 lb that were shipped directly from a western ranch. Shipment occurred in early November in a snowstorm. After processing and vaccination with multivalent inactivated vaccines, the calves were treated uneventfully for respiratory disease during the first 10 days. Shortly after, some calves became lame, and by three weeks 25% of them were lame, febrile, had clear nasal secretions and presented moist, occasional coughing. The calves were pneumonic and did not respond to antimicrobial treatments. Lame calves had swollen hocks and knees. Several of them had subcutaneous swellings on their backs that were edematous on palpation, and a few of them were ulcerated, draining serous exudates. Several of the affected calves lost condition rapidly, even while continuing to eat, and 15 of them eventually died. On necropsy, severe bronchopneumonia was seen, with numerous small coagulative necrosis lesions disseminated throughout the lungs. M. bovis was recovered from noses of affected and healthy calves and from lung lesions. Immunohistochemistry proved that the small coagulative necrosis lesions had M. bovis antigen accumulations. All deaths were reported from the third to the sixth week after arrival. At seven weeks, a group of healthy home-raised calves were placed in nose-to-nose contact across the fence with the affected calves group. No disease was noted in this group of calves, and nasal swab samples were obtained from them at 12 weeks (from receipt of the calf shipment). Isolates of M. bovis obtained from the lungs and noses of affected calves were of a single genomic fingerprint, proving that a single introduction of infection was made. 3 The healthy home-raised calves yielded two different genotypes of M. bovis from their noses, the one associated with the outbreak as well as a different one. Even though polyarthritis was a hallmark of this case, with 25% of calves becoming lame, the number of calves with pneumonia was estimated to be around 85%. Overall, only 20% of M. bovis outbreaks present with lameness 14 while therapy-resistant pneumonia with only moderate loss of appetite are the common signs. Similar presentations in heavier feedlot calves are less frequent than in stockers, and mortality is low or nil. There are reports of delayed-onset pneumonia and polyarthritis in stockers. In these, the first sick calves are seen 2-3 months after arrival, and the disease courses over a one month period. There are no known reasons for this delayed onset. It is speculated that this 4 THE AABP PROCEEDINGS VOL. 38

could occur if the calves mounted a short-lived immune response against M. bovis due to exposure or vaccination at commingling. In avian mycoplasma infections, delayed onset outbreaks are associated with environmental exposure. 9 Potentially, this could also occur in beef operations. Since there is increasing use of vaccination with M. bovis bacterins in stocker calves, the influence of vaccination on nasal shedding should be explored. Experimental data would support the notion that vaccination will not prevent nasal colonization, 11 although field evaluation of the effect of vaccination on nasal colonization or shedding is not available. References 1. Boothby JT, Jasper DE, Thomas CB: Experimental intramammary inoculation with Mycoplasma bovis in vaccinated and unvaccinated cows: effect on the mycoplasma infection and cellular inflammatory response. Cornell Vet 76: 188-197, 1986. 2. Bushnell RB: Mycoplasma mastitis. Vet Clin North Am Large Anim Pract 6: 301-312, 1984. 3. Butler JA, Pinnow CC, Thomson JU, Levisohn S, Rosenbusch RF: Use of arbitrarily primed polymerase chain reaction to investigate Mycoplasma bovis outbreaks. Vet Micro 78: 175-181, 2001. 4. Butler JA, Sickles SA, Johanns CJ, Rosenbusch RF: Pasteurization of discard mycoplasma mastitic milk used to feed calves: thermal effects on various mycoplasma. J Dairy Sci 83: 2285-2288, 2000. 5. Ghadersohi A, Fayazi Z, Hirst RG: Development of a monoclonal blocking ELISA for the detection of antibody to Mycoplasma bovis in dairy cattle and comparison to detection by PCR. Vet Immunol Immunopathol 104: 183-193, 2005. 6. Godden SM, Fetrow JP, Fiertag JM, Green LR, Wells SJ: Economic analysis of feeding pasteurized nonsaleable milk versus conventional milk replacer to dairy calves. J Am Vet Med Assoc 226: 1547-1554, 2005. 7. Gonzales RN, Wilson DJ: Mycoplasmal mastitis in dairy herds. Vet Clin North Am Food Anim Pract 19: 199-221, 2003. 8. Maeda T, Shibara Y, Kimura K, Wada Y, Sato K, Imada Y, Ishikawa Y, Kadota K: Mycoplasma bovis-associated suppurative otitis media and pneumonia in bull calves. J Comp Pathol 129: 100-110, 2003. 9. Marois C, Savoye C, Kobisch M, Kempf I: A reverse transcription- PCR assay to detect viable Mycoplasma synoviae in poultry environmental samples. Vet Micro 89: 17-28, 2002. 10. Maunsell F, Donovan A, Risco C, Hernandez J, Brown M: Field evaluation of a Mycoplasma bovis bacterin in young dairy calves. 15th Congress of the International Organization for Mycoplasmology, Athens, GA, 2004, p. Poster 184. 11. Nicholas R, Ayling R, Stipkovits L: An experimental vaccine for calf pneumonia caused by Mycoplasma bovis: clinical, cultural, serological and pathological findings. Vaccine 20: 3569-3575, 2002. 12. Pfutzner H: Tenacity of Mycoplasma bovis. Zbl Bakt Hyg A 258: 38-41, 1984. 13. Poumarat F, Solsona M, Boldini M: Genomic, protein and antigenic variability of Mycoplasma bovis. Vet Micro 40: 305-321, 1994. 14. Spire M, Sargent J, Blasi D, Rosenbusch RF: Kansas survey of Mycoplasma in stockers. Bovine Veterinarian May-June: 12-16, 2002. 15. Vanden Bush TJ, Rosenbusch RF: Mycoplasma bovis induces apoptosis of bovine lymphocytes. FEMS Immunol Med Microbiol 32: 97-103, 2002. SEPTEMBER, 2005 5